• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型膜设计的聚醚砜过滤器可降低滴注式可调浓缩器无细胞和浓缩腹水回输疗法(DC-CART)中过滤膜的阻塞率。

Novel Membrane Designed Polyether Sulfone Filter Reduces Filtration Membrane Obstruction Rate in Drop-Type With Adjustable Concentrator Cell-Free and Concentrated Ascites Reinfusion Therapy (DC-CART).

作者信息

Inui Keita, Yamada Yosuke, Aomura Daiki, Sonoda Kosuke, Harada Makoto, Hashimoto Koji, Kamijo Yuji

机构信息

Department of Nephrology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.

出版信息

Artif Organs. 2025 Apr;49(4):592-599. doi: 10.1111/aor.14932. Epub 2024 Dec 23.

DOI:10.1111/aor.14932
PMID:39714023
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11974482/
Abstract

BACKGROUND

In cell-free and concentrated ascites reinfusion therapy (CART), filtration membrane obstruction during the ascites processing step is an important clinical problem. A novel membrane designed polyether sulfone filter (n-PES) was developed to reduce filter membrane obstruction. However, no clinical studies have compared the performance of n-PES filters with that of conventional filters. Therefore, we aimed to assess whether n-PES filters reduce membrane obstruction compared to conventional polyethylene (PE) filters during CART ascites processing.

METHODS

This was a single-center, retrospective, observational, controlled cohort study. We compared ascites processing records from the drop-type with adjustable concentrator CART (DC-CART) sessions that used n-PES filters with those that used conventional PE filters. The primary outcome was the occurrence rate of membrane obstruction. Propensity score matching was used to assemble DC-CART sessions with comparable baseline ascites characteristics.

RESULTS

Among the 173 DC-CART sessions, 31 sessions using n-PES filters and 31 using PE filters with similar propensity scores were included in the analysis. The rate of filter membrane obstruction was significantly lower in the n-PES group than in the PE group (p = 0.049). Additionally, the total treatment time was significantly shorter for the n-PES group (p = 0.006). No sessions experienced issues with the processing procedure.

CONCLUSION

This is the first study to demonstrate that an n-PES filter reduces the incidence of filter membrane obstruction in clinical CART sessions using human ascites. The n-PES filter may reduce the burden on the medical staff performing CART.

摘要

背景

在无细胞浓缩腹水回输疗法(CART)中,腹水处理步骤中的滤膜阻塞是一个重要的临床问题。一种新型的膜设计聚醚砜过滤器(n-PES)被开发出来以减少滤膜阻塞。然而,尚无临床研究比较n-PES过滤器与传统过滤器的性能。因此,我们旨在评估在CART腹水处理过程中,与传统聚乙烯(PE)过滤器相比,n-PES过滤器是否能减少膜阻塞。

方法

这是一项单中心、回顾性、观察性、对照队列研究。我们比较了使用n-PES过滤器的滴注式可调浓缩器CART(DC-CART)疗程与使用传统PE过滤器的DC-CART疗程的腹水处理记录。主要结局是膜阻塞的发生率。采用倾向得分匹配法来汇集具有可比基线腹水特征的DC-CART疗程。

结果

在173个DC-CART疗程中,分析纳入了31个使用n-PES过滤器和31个使用具有相似倾向得分的PE过滤器的疗程。n-PES组的滤膜阻塞率显著低于PE组(p = 0.049)。此外,n-PES组的总治疗时间显著更短(p = 0.006)。所有疗程在处理过程中均未出现问题。

结论

这是第一项证明n-PES过滤器可降低使用人腹水的临床CART疗程中滤膜阻塞发生率的研究。n-PES过滤器可能减轻进行CART的医务人员的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/4d619d02f628/AOR-49-592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/e77f4bb2aa69/AOR-49-592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/6c4493edaddf/AOR-49-592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/9932221a99d2/AOR-49-592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/4d619d02f628/AOR-49-592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/e77f4bb2aa69/AOR-49-592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/6c4493edaddf/AOR-49-592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/9932221a99d2/AOR-49-592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40f0/11974482/4d619d02f628/AOR-49-592-g005.jpg

相似文献

1
Novel Membrane Designed Polyether Sulfone Filter Reduces Filtration Membrane Obstruction Rate in Drop-Type With Adjustable Concentrator Cell-Free and Concentrated Ascites Reinfusion Therapy (DC-CART).新型膜设计的聚醚砜过滤器可降低滴注式可调浓缩器无细胞和浓缩腹水回输疗法(DC-CART)中过滤膜的阻塞率。
Artif Organs. 2025 Apr;49(4):592-599. doi: 10.1111/aor.14932. Epub 2024 Dec 23.
2
Technical Performance and Clinical Effectiveness of Drop Type With Adjustable Concentrator-Cell Free and Concentrated Ascites Reinfusion Therapy.可调浓缩器式滴注型无细胞浓缩腹水回输疗法的技术性能与临床疗效
Artif Organs. 2017 Dec;41(12):1135-1144. doi: 10.1111/aor.12933. Epub 2017 Jun 7.
3
Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapy.新型多环滚压泵单元式腹水自动过滤浓缩设备用于无细胞浓缩腹水再回输治疗
Artif Organs. 2020 Aug;44(8):856-872. doi: 10.1111/aor.13681. Epub 2020 Jun 2.
4
Improvement of Major Problems in the Cell-Free and Concentrated Ascites Reinfusion Therapy System─Constructing of Cell-Free and Concentrated Ascites Reinfusion Therapy System Using External Pressure for Filtration.无细胞浓缩腹水回输治疗系统主要问题的改进─利用外压过滤构建无细胞浓缩腹水回输治疗系统
Ther Apher Dial. 2019 Jun;23(3):233-236. doi: 10.1111/1744-9987.12829.
5
Characteristics of Patients and Their Ascites Who Underwent Repeated Cell-Free and Concentrated Ascites Reinfusion Therapy.接受重复无细胞浓缩腹水回输治疗的患者及其腹水的特征。
Ther Apher Dial. 2015 Aug;19(4):342-8. doi: 10.1111/1744-9987.12343.
6
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.无细胞浓缩腹水回输治疗恶性腹水的不良反应:单中心经验。
BMC Cancer. 2022 Mar 14;22(1):268. doi: 10.1186/s12885-022-09298-6.
7
Assessing protein and albumin recovery rates in different ascites filtration membrane washing methods for cell-free and concentrated ascites reinfusion therapy.评估用于无细胞浓缩腹水回输治疗的不同腹水滤过膜冲洗方法中的蛋白质和白蛋白回收率。
Fujita Med J. 2024 May;10(2):53-59. doi: 10.20407/fmj.2023-005. Epub 2024 Feb 15.
8
Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites.无细胞浓缩腹水回输治疗恶性腹水滤过膜的超微结构观察。
Ther Apher Dial. 2022 Jun;26(3):649-657. doi: 10.1111/1744-9987.13747. Epub 2021 Oct 28.
9
Drug retention by inline filters--effect of positively charged polyethersulfone filter membranes on drug solutions with low concentration.在线过滤器对药物的截留作用——带正电荷的聚醚砜过滤膜对低浓度药物溶液的影响。
Eur J Pharm Sci. 2011 Sep 18;44(1-2):49-56. doi: 10.1016/j.ejps.2011.06.004. Epub 2011 Jun 17.
10
Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell-free and concentrated ascites reinfusion therapy, in a postmarketing clinical study.在一项上市后临床研究中评估 Plasauto μ 型机器在无细胞和浓缩腹水再输注治疗中的性能、操作性和安全性,这是一种新型机器。
Ther Apher Dial. 2021 Aug;25(4):407-414. doi: 10.1111/1744-9987.13658. Epub 2021 May 19.

本文引用的文献

1
Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience.无细胞浓缩腹水回输治疗恶性腹水的不良反应:单中心经验。
BMC Cancer. 2022 Mar 14;22(1):268. doi: 10.1186/s12885-022-09298-6.
2
[Albumin substitution : A review of the indications in general internal medicine].[白蛋白替代治疗:普通内科适应症综述]
Rev Med Suisse. 2021 Nov 24;17(760):2022-2026.
3
Ultrastructural observation of filtration membrane in cell-free and concentrated ascites reinfusion therapy for malignant ascites.
无细胞浓缩腹水回输治疗恶性腹水滤过膜的超微结构观察。
Ther Apher Dial. 2022 Jun;26(3):649-657. doi: 10.1111/1744-9987.13747. Epub 2021 Oct 28.
4
Effectiveness of Cell-Free and Concentrated Ascites Reinfusion Therapy in the Treatment of Malignancy-Related Ascites: A Systematic Review and Meta-Analysis.无细胞浓缩腹水回输疗法治疗恶性腹水的有效性:一项系统评价与Meta分析
Cancers (Basel). 2021 Sep 29;13(19):4873. doi: 10.3390/cancers13194873.
5
[Breast Cancer with Cancerous Ascites with Good QOL by KM-CART-A Case Report].[通过KM-CART治疗的伴有癌性腹水且生活质量良好的乳腺癌——病例报告]
Gan To Kagaku Ryoho. 2020 Dec;47(13):1983-1985.
6
Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.细胞游离液和浓缩腹水再输注疗法(KM-CART)治疗恶性腹水的可行性、疗效和安全性。
Artif Organs. 2020 Oct;44(10):1090-1097. doi: 10.1111/aor.13691. Epub 2020 Apr 20.
7
Mitigation of Membrane Fouling Using an Electroactive Polyether Sulfone Membrane.使用电活性聚醚砜膜减轻膜污染
Membranes (Basel). 2020 Jan 30;10(2):21. doi: 10.3390/membranes10020021.
8
Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.血清白蛋白升高效应的验证——细胞游离浓缩腹水再输注疗法治疗腹水患者:一项回顾性对照队列研究。
Sci Rep. 2019 Jul 15;9(1):10195. doi: 10.1038/s41598-019-46774-9.
9
Hypoalbuminemia: Pathogenesis and Clinical Significance.低蛋白血症:发病机制与临床意义。
JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193. doi: 10.1002/jpen.1451. Epub 2018 Oct 4.
10
CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.CART:用于治疗恶性肿瘤相关腹水的无细胞浓缩腹水回输疗法
Transfus Apher Sci. 2017 Oct;56(5):703-707. doi: 10.1016/j.transci.2017.08.018. Epub 2017 Aug 30.